Pfizer and BioNTech will work with The Biovac Institute to produce the Pfizer/BioNTech vaccine against COVID-19 for distribution in Africa. The Biovac plant in Cape Town is scheduled to begin receiving vaccine components from Europe by the end of 2021, with the first doses produced in 2022. All of them will be distributed exclusively within the 55 member states of the African Union.
Pfizer and BioNTech will work with The Biovac Institute to produce the Pfizer/BioNTech vaccine against COVID-19 for distribution in Africa. The Biovac plant in Cape Town is scheduled to begin receiving vaccine components from Europe by the end of 2021, with the first doses produced in 2022. All of them will be distributed exclusively within the 55 member states of the African Union. 
investors.pfizer.com
English (US) 